Supplementary Materials and Methods from The Anti-HER3 mAb Seribantumab Effectively Inhibits Growth of Patient-Derived and Isogenic Cell Line and Xenograft Models with Oncogenic NRG1 Fusions

Authors :: Romel Somwar
Marc Ladanyi
Shawn M. Leland
Elisa de Stanchina
Marissa S. Mattar
Inna Khodos
Morana Vojnic
Exequiel M. Sisso
Renate I. Kurth
Lukas Delasos
Zebing Liu
Eric Gladstone
Whitney J. Sisso
Allan J.W. Lui
Igor Odintsov
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Supplementary Materials and Methods contains additional details of experimental procedures.

Tools